These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1015 related items for PubMed ID: 9019768

  • 21. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN, Barrera L.
    Medicina (B Aires); 2007; 67(3):231-7. PubMed ID: 17628909
    [Abstract] [Full Text] [Related]

  • 22. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
    Park SK, Kim CT, Song SD.
    Int J Tuberc Lung Dis; 1998 Nov; 2(11):877-84. PubMed ID: 9848607
    [Abstract] [Full Text] [Related]

  • 23. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J.
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract] [Full Text] [Related]

  • 24. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
    Khudushina TA, Voloshina EP, Adamovich NV, Maslakova MG, Terekhova ND.
    Probl Tuberk Bolezn Legk; 2005 May; (12):37-9. PubMed ID: 16496762
    [Abstract] [Full Text] [Related]

  • 25. Chemotherapy of chronic pulmonary tuberculosis with polyresistant bacteria with reference to ethambutol and capreomycin.
    Radenbach KL.
    Scand J Respir Dis Suppl; 1968 May; 65():195-206. PubMed ID: 4978461
    [No Abstract] [Full Text] [Related]

  • 26. [Surgical treatment for pulmonary tuberculosis with Mycobacterium resistance to drugs].
    Ots ON, Agkatsev TV, Perel'man MI.
    Probl Tuberk Bolezn Legk; 2009 May; (2):42-9. PubMed ID: 19382642
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Monitoring of chemotherapy in patients with pulmonary tuberculosis by the blood bacteriostatic activity-determining test].
    Manicheva OA, Skvortsova LA, Pavlova MV, Sapozhnikova NV, Archakova LI, Vishnevskiĭ BI.
    Probl Tuberk Bolezn Legk; 2008 May; (5):14-7. PubMed ID: 18711812
    [Abstract] [Full Text] [Related]

  • 30. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 31. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S, Caugant DA, Sandven P, Mariandyshev AO, Bjune G.
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [Abstract] [Full Text] [Related]

  • 32. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
    Fomicheva NI, Terentieva AS.
    Probl Tuberk; 1981 Dec; (12):23-6. PubMed ID: 6801645
    [No Abstract] [Full Text] [Related]

  • 33. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A, Gogate A.
    Indian J Public Health; 1998 Dec; 42(4):126-30. PubMed ID: 10389525
    [Abstract] [Full Text] [Related]

  • 34. [An evaluation of the results of the use of a short-duration chemotherapy regimen (3+3) in cases with tuberculosis of the respiratory tract in 1986].
    Didilescu C.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989 Dec; 38(2):173-5. PubMed ID: 2555903
    [No Abstract] [Full Text] [Related]

  • 35. Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis.
    Krüüner A, Pehme L, Ghebremichael S, Koivula T, Hoffner SE, Mikelsaar M.
    Clin Infect Dis; 2002 Jul 15; 35(2):146-55. PubMed ID: 12087520
    [Abstract] [Full Text] [Related]

  • 36. [Clinical significance of Mycobacterium tuberculosis polydrug resistance in chronic destructive forms of pulmonary tuberculosis].
    Bialik IB, Klimenko MT.
    Probl Tuberk; 1980 Oct 15; (10):68-70. PubMed ID: 6776517
    [No Abstract] [Full Text] [Related]

  • 37. [Prognostic value of isolation of drug-resistant Mycobacterium tuberculosis].
    Astionenko AA.
    Vrach Delo; 1978 Dec 15; (12):27-30. PubMed ID: 105475
    [No Abstract] [Full Text] [Related]

  • 38. [Bacterial excretion and the bacteriostatic activity of the blood in the chemotherapy of middle-aged and elderly tuberculosis patients].
    Ginzburg TS, Iakimets VP.
    Probl Tuberk; 1983 May 15; (5):57-61. PubMed ID: 6408638
    [No Abstract] [Full Text] [Related]

  • 39. Chemotherapy of chronic destructive tuberculosis of the lungs and some disputable drugs.
    Schmelev NA.
    Scand J Respir Dis Suppl; 1968 May 15; 65():147-50. PubMed ID: 4978458
    [No Abstract] [Full Text] [Related]

  • 40. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T, Hasegawa N, Satou R, Komatsu H, Kawada K.
    Kekkaku; 1998 Jul 15; 73(7):471-6. PubMed ID: 9739579
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.